Tickers

EXPD — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-22 09:45:32.726004 UTC · finished 2026-09-22 09:56:22.514441 UTC

1. Composite Trajectory Verdict

For a non-asset-based logistics company, the income statement and cash flow statement carry the most weight because profitability and cash conversion drive value, while the balance sheet is consistently strong with no debt.

Composite Trajectory: Mixed

Annual earnings have flattened (operating income +1%, net earnings unchanged) despite revenue growth (+4%), while quarterly results show strong acceleration (Q2 revenue +32%, operating income +41%). However, operating cash flow has not kept pace (Q2 flat, YTD down 6.5%), and cash has declined 21% in six months due to aggressive share repurchases. The balance sheet remains debt-free but equity fell 10% in H1 2026 from capital returns. These offsetting signals produce a Mixed composite trajectory.

2. Red Flags

  • Operating margin compression: fell from 10.1% (2023) to 9.5% (2025) as overhead expenses grew 10% versus 4% revenue growth (10-K 2025, Consolidated Statements of Operations).
  • Divergence between earnings and operating cash flow: 2024 net earnings $810M vs operating cash flow $723M; Q2 2026 net earnings $266M vs operating cash flow $179M (10-K 2025, Consolidated Statements of Cash Flows; 10-Q Q2 2026, Consolidated Statements of Cash Flows).
  • Sharp cash decline: cash and equivalents fell 21% in H1 2026 to $1,031M from $1,314M at year-end 2025, driven by $642.5M in share repurchases and $105.8M dividends (10-Q Q2 2026, Consolidated Balance Sheets; 10-Q Q2 2026, Consolidated Statements of Cash Flows).
  • Accounts receivable surged 30% in H1 2026 to $2,631M from $2,022M, outpacing YTD revenue growth of 18%, partly due to extended payment terms (10-Q Q2 2026, Consolidated Balance Sheets; 10-Q Q2 2026, MD&A).
  • $25M restructuring charge in Q2 2026 for Global Technology group (10-Q Q2 2026, MD&A).
  • Net foreign currency transactional losses of $28M in 2025 versus $12M gains in 2024 (10-K 2025, MD&A).
  • Tax contingencies expected to increase in 2026 (10-K 2025, MD&A).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual results show revenue growth decelerating (2023: +14%, 2024: +4%) with operating income nearly flat (+1% in 2025) and net earnings unchanged at $810M for two consecutive years (10-K 2025, Consolidated Statements of Operations). Diluted EPS rose 4% to $5.95 only due to a 4% reduction in share count (10-K 2025, Consolidated Statements of Operations). Quarterly Q2 2026 shows a sharp acceleration: revenue +32%, operating income +41%, net earnings +45%, and EPS +51% versus Q2 2025 (10-Q Q2 2026, Consolidated Statements of Operations). However, only one quarterly YoY comparison is available, limiting trend assessment. The mix of flat annual earnings and strong quarterly growth yields a Mixed trajectory.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow rebounded to $1,006M in 2025 from a low of $723M in 2024, but remains below the 2023 level of $1,053M (10-K 2025, Consolidated Statements of Cash Flows). In H1 2026, operating cash flow declined 6.5% to $488M from $522M in H1 2025, while Q2 2026 cash flow was flat at $179M versus Q2 2025 (10-Q Q2 2026, Consolidated Statements of Cash Flows). Free cash flow (operating cash flow minus capex) was approximately $463M in H1 2026 vs $493M in H1 2025. Cash on hand dropped 21% in six months due to $748M in combined buybacks and dividends (10-Q Q2 2026, Consolidated Statements of Cash Flows). The volatility and recent decline amid strong earnings produce a Mixed signal.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

The balance sheet remains debt-free aside from lease liabilities, with total assets growing 3% annually to $4,894M at year-end 2025 (10-K 2025, Consolidated Balance Sheets). However, in H1 2026, equity fell 10% to $2,121M from $2,358M as $642.5M in repurchases and $105.8M in dividends exceeded retained earnings (10-Q Q2 2026, Consolidated Balance Sheets). Current liabilities jumped 23% to $2,559M, driven by a 30% rise in accounts payable and accrued expenses to $1,468M and $608M respectively, while cash fell 21% to $1,031M (10-Q Q2 2026, Consolidated Balance Sheets). Working capital (current assets minus current liabilities) was $1,448M at June 30, 2026 (10-Q Q2 2026, MD&A). The combination of strong annual equity growth and sharp quarterly equity reduction yields a Mixed trajectory.

6. Data Gaps

  • Q1 2026 standalone income statement and cash flow data (10-Q Q1 2026 filing truncated).
  • Q3 2025 and Q4 2025 quarterly results for sequential trend analysis.
  • Quarterly segment operating income breakdowns (only annual provided in 10-K).
  • Explicit free cash flow metric (not reported; derived from operating cash flow and capex).
  • Days Sales Outstanding (DSO) not directly calculable due to pass-through customs duty billings (10-K 2025, MD&A).
  • Full-year 2026 capital expenditure guidance inconsistency ($60M per Q2 10-Q vs $100M per 10-K).
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status